Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Name: Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Published: 2023
License: Public Domain

GlaxoSmithKline · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

chronic-obstructive pulmonary-disease

pulmonary disease, chronic obstructive, single ascending dose, repeat dose, phosphatidylinositol 4-kinase beta (pi4kb) inhibitor, chronic obstructive pulmonary disease (copd), interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Related documents